24th Mar 2016 07:00
Progility plc
("Progility" or "the Group")
Interim Results
Progility plc (AIM: PGY) the Professional Services, Healthcare and Communications firm is pleased to announce its Interim Results for the six months to 31 December 2015.
The results for the six months to 31 December 2015 once again show considerable growth in sales, up over 23% on the prior period, primarily from acquisitions. On consideration of the Group's growth into a more stable set of businesses, the Board has determined that it is now appropriate to report the businesses' performance in three segments; Professional Services (comprising the training and recruitment businesses), Healthcare (comprising Starkstrom, including its nascent overseas activities) and Communications (which is comprised of our communications technology businesses in India and Australia). Professional Services have improved markedly in the period; Healthcare has largely been a case of investing for future geographic expansion and Communications has been a mixture of the very successful integration of the Indian business set against a continued falling off of customer activity in Australia.
Six months' highlights - good revenue growth, investment and successful integration
· Revenues up to £30.5 million (2014: £24.7 million)
· Operating loss before highlighted items £0.1 million (2014: Loss £0.1 million)
· Loss before tax and highlighted items £1.4 million (2014: £1.2 million)
· Loss before tax £1.4 million (2014: Profit £1.7 million)
· Gross margin improvement to 38.6% from 36.2%
· Organic investment in Healthcare geographic expansion
· Acquisitions of last year successfully integrated into each segment
· Difficult economic environment in Australia
Wayne Bos, Executive Chairman, commented:
"The integration of our acquisitions in 2014 into the Group has progressed well. Healthcare through Starkstrom continues as a leader in the UK and we have invested organically into its growth overseas, particularly in the Middle East.
Professional Services, through a combination of focused leadership and better understanding and servicing the needs of our customers, has enjoyed strong profit growth, and the ILX brand in particular continues to be recognised as a mark of superior quality.
The Communications business has been a tale of two sides, with India, new to the Group, demonstrating why it was such an excellent addition, whilst Australia has necessarily been affected by the poor health of its mining and energy industries, where our Communications business has been badly hit.
Overall, we continue to pursue our strategic growth objectives. The outturn for the year to June 2016 as a whole remains heavily dependent on the second half of the year. Actions taken by management in the first half to reduce costs and increase revenue have begun to improve performance across most areas.
We fully intend to continue our strategy of transformation and organic growth over the next six months."
Enquiries:
Progility plc |
|
Wayne Bos, Executive Chairman | 020 7371 4444 |
Hugh Cawley, CFO |
|
|
|
SPARK Advisory Partners Limited (Nominated Advisor) |
|
Mark Brady/Sean Wyndham-Quin | 0203 368 3551 |
|
|
W H Ireland Limited (Broker) |
|
Adrian Hadden | 020 7220 1666 |
Executive Chairman and Financial Review
Introduction
The results for the six months to 31 December 2015 once again show considerable growth in sales, up over 23% on the prior period last year, primarily from acquisitions. On consideration, the Board has determined that it is appropriate now to report the businesses' performance in three segments; Professional Services (comprising the training and recruitment businesses), Healthcare (comprising Starkstrom, including its nascent overseas activities) and Communications (which is comprised of our communications technology businesses in India and Australia). Professional Services have improved markedly in the period; Healthcare has largely been a case of investing for future geographic expansion and Communications has been a mixture of the very successful integration of the Indian business set against a continued falling off of customer activity in Australia.
Highlights - good revenue growth, organic investment and successful integration
· Revenues up 23.4% to £30.5 million (2014: £24.7 million)
· Operating loss before highlighted items £0.1 million (2014: Loss £0.1 million)
· Loss before tax and highlighted items £1.4 million (2014: £1.2 million)
· Loss before tax £1.4 million (2014: Profit £1.7 million)
· Gross margin improvement to 38.6% from 36.2%
· Organic investment in Healthcare geographic expansion
· Acquisitions of last year successfully integrated into each segment
· Difficult economic environment in Australia
The last six months have seen considerable improvement in the efficiency of each of the businesses, and, although, the investment required to achieve these improvements has thus far masked the underlying profitability increase, the Group is generally in better financial shape now. With the hiatus in M&A activity over the period, the shape of central management functions has also been adapted better to suit the circumstances of the Group.
Overview and summary of results
The geographic spread of our Group is hugely helpful to a developing business, particularly in the digital age; it allows access for our offerings to more markets, as is clearly illustrated with the international spread of the project management training business. We now report the Group in three segments, however, rather than geographically, since the performance is effectively driven and managed more by common product and customer characteristics than by country.
The profitability of the Professional Services segment has improved significantly in the current period, particularly since the appointment of a new Managing Director to ILX in the spring of 2015, and bringing all parts of ILX's operations under his direct responsibility. The Recruitment business, specialising in information management resources, has a strong niche position but growth is challenging.
The predominantly UK-based Healthcare business has integrated well within Progility since the acquisition of Starkstrom in July 2014. Measures to streamline the operations have been undertaken. Meanwhile, exploitation of the strength of the Starkstrom brand within the Healthcare sector has been the thrust behind developing a distributor-based model for sales outside the UK and considerable investment has been put into growing the overseas market from new offices opened in Dubai; this remains in the investment phase and the fruits of those labours are not yet visible.
The Communications segment of our Group has experienced different levels of profitability, and absolutely justifies the timing and nature of the Indian acquisition. The telephony products are very similar, in providing communications infrastructure solutions, although the experiences of our customers have been very different over the past year or so. The Indian economy has been thriving and our business there reflects that, whereas Australia, has continued to suffer from substantially lower activity in the mining sector. Our involvement in healthcare infrastructure in Australia has been helpful, as has the relatively recent appointment of a highly capable and fully focused chief executive from outside the group.
Summary of Results and operating performance
The table below sets out a summary of our results:
|
|
| Unaudited six | Unaudited restated | ||
|
|
| months ended | six months ended | ||
|
|
| 31 December 2015 | 31 December 2014 | ||
|
|
| £ ' 000 |
| £ ' 000 |
|
Revenue |
|
| 30,493 |
| 24,714 |
|
Gross profit |
|
| 11,769 |
| 8,956 |
|
|
|
|
|
|
|
|
Operating loss before highlighted items | (87) |
| (131) |
| ||
Highlighted items |
| - |
| 2,916 |
| |
Operating (loss) / profit |
| (87) |
| 2,785 |
| |
Net finance costs |
| (1,267) |
| (1,038) |
| |
(Loss) / profit before tax |
| (1,354) |
| 1,747 |
| |
|
|
|
|
|
|
|
Professional Services' revenues grew 16.4% against prior year, from £7.49m to £8.71m. All the revenue increase came as a result of the Woodspeen acquisition, whilst profitability within the segment more than doubled from £0.45m to £0.95m, including a contribution from the acquisition, but the bulk of the improvement arose organically from operational and efficiency improvements.
The Healthcare segment, in the UK at least, makes the bulk of its sales and profits in the second half of the year; the business outside the home market is insufficiently developed yet to assess in such terms. Turnover overall was 5% down on the prior year's equivalent period, reflecting to an extent the choice of margin over turnover. Investment in the overseas expansion, which we believe will show a return over time, has adversely affected the bottom line with a loss of £0.05m compared to a profit of £0.24m in the first six months of last year.
The acquisition of the Indian business in the Communications segment has proved to be valuable. On a financial basis alone, the business which was acquired at a cost of just €1m, has so far been able to remit some £0.6m of dividends to the UK and continues to generate profits in its home market. India has achieved profitability in line with the Board's expectations and has allowed the segment as a whole to remain profitable despite the significant challenges experienced by its sister business in Australia. The net result of a 42.8% increase in turnover afforded by the acquisition, from £11.33m to £16.19m, was accompanied by a relatively modest 33.8% increase in profits from £0.13m to £0.17m.
Central costs reflect, inter alia, the expense of a variety of measures to cut our cloth according to our needs in the world of less corporate activity and the run rate now is below that reflected in the £1.16m (2014 £0.94m) for the period to December 2015.
The operating loss before highlighted items of £0.09m - and there are no items being highlighted in the current reporting period, as against a net profit of £2.79m in the equivalent period in 2014, relating principally to the bargain gain on the Indian acquisition - is slightly improved against a loss of £0.13m in 2014, although it should be pointed out that the trend now established is one of improving profitability in Professional Services and Communications, whereas the continuing investment in Healthcare is being made in the expectation of higher returns.
With the level of debt, principally incurred to fund acquisitions, increasing between the periods, the net interest charge rose to £1.27m (2014 £1.04m), giving rise to a loss before tax of £1.35m for the six months to December 2015 (2014: loss before tax and highlighted items £1.17m).
Cash flow, net debt and facilities
Cash absorbed by operations in the period was £0.37m (2014: £0.07m), principally reflecting a substantially greater settlement of creditors than receipts from debtors would fund. Capitalise-able investment activity (as distinct from the 'investment' in establishing our presence in the Healthcare business overseas) was substantially lower at £0.86m in the half year than in the equivalent period in 2014 (£6.78m) and mainly comprised payment of deferred consideration for a prior period acquisition, the settlement of which was funded by further borrowing in the form of shareholder loans.
At the balance sheet date, the Group's debt facilities, including, where appropriate, rolled up interest, comprised £0.2m by way of a fixed term facility (2014 £1.0m), £2.39m of invoice discounting facility (2014 £2.0m), £1.36m of third party borrowings (2014 £2.72m) and £17.1m of shareholder loans (including convertible loan notes) (2014 £13.4m) and a standard bank overdraft of £nil (2014 £0.3m). At the same date the Group's cash and cash equivalents amounted to £3.46m (2014 £3.22m).
Shareholder loans
The Group's acquisitions have been funded in recent years entirely through the issue of 12% loan notes which are listed on the Channel Islands Stock Exchange.
The subscriber for all these notes has been DNY Investments Limited, a company which is an asset of the DNY Trust, a family trust of which Wayne Bos, Executive Chairman, is a discretionary beneficiary and of which Praxis Trustees Limited, the company's controlling shareholder, is trustee. Praxis Trustees remain supportive of the Group's strategy.
Dividend
The Board does not recommend a dividend for the period ended 31 December 2015. Given the Group's strategic direction and historic financial performance, the Board does not envisage the Company's paying a dividend for the foreseeable future.
Outlook
The board believes that the improvements which have been evident throughout the Group's operations in the last six months will continue into the second half of the year. Given this is generally a second-half weighted business and the effect of improvement actions already taken should begin to come through, the board is looking forward to a better second half performance.
By order of the Board
Wayne M Bos Executive Chairman | Hugh C L Cawley Chief Financial Officer |
23 March 2016 |
|
Unaudited consolidated statement of Comprehensive Income for the six months ended 31 December 2015
|
| Unaudited six months ended 31.12.2015 |
| Unaudited six months ended 31.12.2014 Restated |
|
Audited year ended 30.06.15 |
|
| Note | £000 |
| £000 |
| £000 |
|
Revenue | 4 | 30,493 |
| 24,714 |
| 60,056 |
|
|
|
|
|
|
|
|
|
Cost of Sales |
| (18,724) |
| (15,758) |
| (37,078) |
|
|
|
|
|
|
|
|
|
Gross profit |
| 11,769 |
| 8,956 |
| 22,978 |
|
|
|
|
|
|
|
|
|
Administrative and distribution expenses - excluding highlighted items |
| (11,856) |
| (9,087) |
| (22,793) |
|
Administrative and distribution expenses - highlighted items | 5 | - |
| (311) |
| (447) |
|
Total administrative and distribution expenses |
| (11,856) |
| (9,398) |
| (23,240) |
|
|
|
|
|
|
|
|
|
Other income - highlighted items | 5 | - |
| 3,227 |
| 3,227 |
|
Other expenses - highlighted items | 5 | - |
| - |
| (229) |
|
|
|
|
|
|
|
|
|
Operating (loss)/profit before highlighted items |
| (87) |
| (131) |
| 185 |
|
Highlighted items | 5 | - |
| 2,916 |
| 2,551 |
|
Operating (loss)/profit |
| (87) |
| 2,785 |
| 2,736 |
|
|
|
|
|
|
|
|
|
Finance income |
| 124 |
| - |
| 65 |
|
|
|
|
|
|
|
|
|
Finance costs |
| (1,391) |
| (1,038) |
| (2,296) |
|
|
|
|
|
|
|
|
|
(Loss)/profit before tax and highlighted items |
| (1,354) |
| (1,169) |
| (2,046) |
|
|
|
|
|
|
|
|
|
Highlighted items |
| - |
| 2,916 |
| 2,551 |
|
|
|
|
|
|
|
|
|
(Loss)/profit before tax |
| (1,354) |
| 1,747 |
| 505 |
|
|
|
|
|
|
|
|
|
Tax charge |
| (433) |
| - |
| (18) |
|
|
|
|
|
|
|
|
|
(Loss)/profit for the period attributable to equity shareholders |
| (1,787) |
| 1,747 |
|
487 |
|
|
|
|
|
|
|
|
|
Currency translation differences on foreign operations |
| 216 |
| (33) |
|
(287) |
|
|
|
|
|
|
|
|
|
Other comprehensive income, net of tax |
| 216 |
| (33) |
| (287) |
|
|
|
|
|
|
|
|
|
Total comprehensive (loss)/profit |
| (1,571) |
| 1,714 |
| 200 |
|
|
|
|
|
|
|
|
|
(Loss)/earnings per share |
|
|
|
|
|
|
|
Basic | 6 | (0.89p) |
| 0.87p |
| 0.24p |
|
Diluted | 6 | (0.89p) |
| 0.87p |
| 0.24p |
|
Unaudited consolidated statement of Financial Position as at 31 December 2015
|
| Unaudited |
| Unaudited |
| Audited |
|
| As at 31.12.2015 |
| As at 31.12.2014 |
| As at 30.6.2015 |
|
|
|
| Restated |
|
|
|
| £000 |
| £000 |
| £000 |
Assets |
|
|
|
|
|
|
Non-current assets |
|
|
|
|
|
|
Property, plant and equipment |
| 1,316 |
| 1,313 |
| 1,449 |
Intangible assets |
| 20,009 |
| 20,289 |
| 20,135 |
Deferred tax asset |
| 848 |
| 849 |
| 888 |
Total non-current assets |
| 22,173 |
| 22,451 |
| 22,472 |
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
Inventories |
| 3,473 |
| 5,020 |
| 4,001 |
Trade and other receivables |
| 13,503 |
| 14,452 |
| 16,554 |
Other current assets |
| 3,182 |
| 2,036 |
| 2,107 |
Tax receivable |
| 49 |
| 82 |
| 41 |
Cash and cash equivalents |
| 3,460 |
| 3,222 |
| 3,538 |
Total current assets |
| 23,667 |
| 24,812 |
| 26,241 |
|
|
|
|
|
|
|
Total assets |
| 45,840 |
| 47,263 |
| 48,713 |
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
Trade and other payables |
| (17,257) |
| (16,894) |
| (19,889) |
Deferred consideration |
| (1,361) |
| (3,123) |
| (2,041) |
Provisions |
| (4,275) |
| (4,327) |
| (4,282) |
Tax liabilities |
| (412) |
| (321) |
| (28) |
Bank and shareholder loans |
| (2,965) |
| (3,639) |
| (3,288) |
Total current liabilities |
| (26,270) |
| (28,304) |
| (29,528) |
|
|
|
|
|
|
|
Non-current liabilities |
|
|
|
|
|
|
Shareholder loans |
| (16,699) |
| (13,094) |
| (14,837) |
Deferred tax liability |
| (199) |
| (277) |
| (199) |
Provisions |
| (180) |
| (76) |
| (90) |
Total non-current liabilities |
| (17,078) |
| (13,447) |
| (15,126) |
|
|
|
|
|
|
|
Total liabilities |
| (43,348) |
| (41,751) |
| (44,654) |
|
|
|
|
|
|
|
Net assets |
| 2,492 |
| 5,512 |
| 4,059 |
|
|
|
|
|
|
|
Issued share capital |
| 19,967 |
| 19,967 |
| 19,967 |
Share premium |
| 114 |
| 114 |
| 114 |
Other reserve |
| 75 |
| 75 |
| 75 |
Merger reserve |
| (14,854) |
| (14,854) |
| (14,854) |
Own shares in trust |
| (2) |
| (50) |
| (2) |
Share option reserve |
| 47 |
| 41 |
| 43 |
Retained earnings |
| (2,740) |
| 296 |
| (953) |
Foreign currency translation reserve |
| (115) |
| (77) |
| (331) |
Total equity |
| 2,492 |
| 5,512 |
| 4,059 |
Unaudited consolidated Cash Flow Statement for the six months to 31 December 2015
|
| Unaudited |
| Unaudited |
| Audited |
|
|
| Six month ended 31.12.2015 |
| Six month ended 31.12.2104 |
| Year ended 30.6.2015 |
|
|
|
|
| Restated |
|
|
|
|
| £000 |
| £000 |
| £000 |
|
(Loss)/Profit from continuing operations |
| (87) |
| 2,785 |
| 2,736 |
|
Adjustments for: |
|
|
|
|
|
|
|
Depreciation and amortisation |
| 525 |
| 403 |
| 1,154 |
|
Loss on fixed asset disposal |
| 56 |
| 86 |
| 86 |
|
Impairment of intangibles |
| - |
| - |
| 229 |
|
Gain on bargain purchase |
| - |
| (3,227) |
| (3,227) |
|
Share option charge |
| 4 |
| 29 |
| 40 |
|
Revaluation of own shares held in trust |
| - |
| - |
| 48 |
|
Movement in inventories |
| 529 |
| 308 |
| 1,101 |
|
Movement in trade and other receivables |
| 1,991 |
| 2,423 |
| 146 |
|
Movement in trade and other payables |
| (3,634) |
| (2,859) |
| (942) |
|
Exchange difference on consolidation |
| 266 |
| 11 |
| (59) |
|
Cash generated from operations |
| (350) |
| (41) |
| 1,312 |
|
|
|
|
|
|
|
|
|
Income tax paid |
| (15) |
| (27) |
| (439) |
|
|
|
|
|
|
|
|
|
Net cash generated from operations |
| (365) |
| (68) |
| 873 |
|
|
|
|
|
|
|
|
|
Investing activities |
|
|
|
|
|
|
|
Interest received |
| 124 |
| - |
| 65 |
|
Purchases of property and equipment |
| (258) |
| (180) |
| (555) |
|
Capitalised expenditure on product development |
| (45) |
| (37) |
| (52) |
|
Acquisition of subsidiaries (net of cash acquired) |
| (680) |
| (6,562) |
| (8,032) |
|
Net cash used in investing activities |
| (859) |
| (6,779) |
| (8,574) |
|
|
|
|
|
|
|
|
|
Financing activities |
|
|
|
|
|
|
|
Proceeds from borrowings |
| 1,901 |
| 9,243 |
| 11,286 |
|
Repayment of borrowings |
| (413) |
| (834) |
| (1,235) |
|
Interest costs paid |
| (158) |
| (135) |
| (408) |
|
Net cash from financing activities |
| 1,330 |
| 8,274 |
| 9,643 |
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
| 106 |
| 1,427 |
| 1,942 |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at start of period |
| 3,350 |
| 1,533 |
| 1,533 |
|
Foreign exchange rate differences |
| 4 |
| (40) |
| (125) |
|
Cash and cash equivalents at end of period |
| 3,460 |
| 2,920 |
| 3,350 |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents comprise: |
|
|
|
|
|
|
|
Cash in hand and at bank |
| 3,460 |
| 3,222 |
| 3,538 |
|
Bank overdraft |
| - |
| (302) |
| (188) |
|
|
| 3,460 |
| 2,920 |
| 3,350 |
|
|
|
|
|
|
|
|
|
Notes to the unaudited accounts:
1. Basis of preparation and accounting policies
These interim financial statements are for the six months ended 31 December 2015. They have been prepared based on the measurement and recognition principles of International Financial Reporting Standards as adopted by the European Union (EU-IFRS) and IFRC interpretations issued and effective at the time of preparing these statements. They do not include all of the information required for full annual financial statements, and should be read in conjunction with the audited financial statements of Progility plc for the year ended 30 June 2015. The financial information for the period ended 31 December 2014 set out in this interim report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The Group's statutory financial statements for the period ended 30 June 2015 have been filed with the Registrar of Companies and can be found on the Group's website www.progility.com. The auditor's report on those financial statements was unqualified and did not contain statements under Section 498(2) or Section 498(3) of the Companies Act 2006. These interim financial statements have been prepared under the historical cost convention as modified by the revaluation of derivative financial instruments. These interim financial statements have been prepared in accordance with the accounting policies detailed in the Group's financial statements for the year ended 30 June 2015 except as documented herein. The accounting policies have been applied consistently throughout the Group for the purposes of preparation of these interim financial statements. The interim financial statements are presented in Sterling (£), which is also the functional currency of the Company.
These interim financial statements have been approved for issue by the board of directors. It should be noted that accounting estimates and assumptions are used in preparation of the interim financial information. Although these estimates are based on management's best knowledge and judgement of current events and actions, actual results may ultimately differ from those estimates. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the interim financial information, are set out in note 2 to the interim financial information. In the future, actual experience may deviate from these estimates and assumptions
The consolidated financial statements include the financial statements of Progility plc and its subsidiaries. There are no associates or joint ventures to be considered.
2. Accounting estimates and key judgements
The preparation of the interim financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and the disclosure of contingent liabilities at the date of the financial statements. Such estimates and assumptions are based on historical experience and various other factors that are believed to be reasonable in the circumstances and constitute management's best judgment of conditions at the date of the financial statements. Key estimates and judgments relate to impairment analysis assumptions, revenue recognition over exam vouchers, stock movement and deferred tax assets. In the future, actual experience may deviate from these estimates and assumptions, which could affect the interim financial statements as the original estimates and assumptions are modified, as appropriate, in the period in which the circumstances change.
Key judgement - Goodwill
In respect of acquisitions, the Group measures goodwill at the acquisition date as:
· The fair value of the consideration transferred; plus the recognised amount of any non-controlling interests in the acquired; plus
· The fair value of the existing equity interest in the acquire; less
· The net recognised amount (generally fair value) of the identifiable assets acquired and liabilities assumed.
When the excess is negative, the negative goodwill is recognised immediately in the profit and loss. Costs related to the acquisition, other than those associated with the issue of debt or equity securities, are expensed as incurred.
Key judgement - Going concern
The Directors, after making enquiries of its loan note holders, considering its financing arrangements and based on its cash flow projections, have a reasonable expectation that the Company and the Group will have adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the annual report and financial statements.
3. Prior year restatements
In line with the 30 June 2015 financial statements, the prior year comparatives in these financial statements have been restated to reflect the following:
3.1 Change to recognition of income from software licences
The Group previously recognised Revenue from software licences at the start of the licence term provided that delivery had occurred. Following a review of the method delivery of the products, it has been determined that the correct practice should be to recognise the revenue over the period of its availability to the user rather than immediately upon the sale.
The opening balance sheet and 2014 comparatives in these financial statements have been restated to reflect this change in revenue recognition. The opening balance at 30 June 2014 has been restated to include an increased deferred income creditor of £1,917,000. During the six months ended 31 December 2015 revenue has been restated upwards by £276,000 to reflect the impact of the revenue recognition policy.
3.2 Recognition of deferred tax asset
A deferred tax asset previously recognised at 30 June 2014 in Progility Pty Ltd did not meet the Groups accounting policy for recoverability. Accordingly the deferred tax assets at 30 June 2014 has been adjusted and restated by £1,069,000.
3.3 Reclassification of costs
Certain costs including administrative and technical staff costs, marketing and IT costs which had previously classified as costs of sales have been reclassified as administrative and distribution expenses as it has been determined that this is the correct classification of these costs. The amount of this restatement in the six months to 31 December 2015 was £871,000, this has no impact on the reported results for the period.
3.4 Reclassification of development costs
Starkstrom Ltd capitalised Development costs which following review did not meet the Groups accounting policy for capitalisation. Accordingly the capitalised development costs at acquisition and to 31 December 2014 have been adjusted and restated by £8,000.
Summary of restatements
The impact of the above restatements on previously reported amounts is summarised below:
| Net assets at 31.12.14 | Profit for the six months ended 31.12.14 | Net assets at 30.6.14 |
| £'000 | £'000 | £'000 |
Previously stated amounts | 8,092 | 1,393 | 6,672 |
3.1 Recognition of software licence revenue | (1,641) | 276 | (1,917) |
3.2 Deferred tax asset | (1,069) | - | (1,069) |
3.3 Reclassification of costs | - | - | - |
3.4 Development costs | 8 | 8 | - |
Foreign exchange difference | 122 | 37 | 85 |
| 5,512 | 1,714 | 3,771 |
4. Segmental reporting
In accordance with IFRS 8 the Group's operating segments are based on the reports reviewed by the Executive Directors that are used to make strategic decisions.
The Group reports its results in three segments:-
Professional Services - The Group's Professional operations comprise the training, recruitment and consultancy activities operating in the UK, Dubai, Australia and New Zealand.
Healthcare - The Group's Health operations comprise the activities of Starkstrom Limited and Progility DMCC.
Communications - The Group's Technology operations comprise the technology solutions goods and services businesses which operate in Australia and India
Segment profit or loss consists of earnings before interest, tax and highlighted items. This measurement excludes the effects of non-recurring expenditure from the operating segments such as restructuring costs and purchased intangibles amortisation. Interest income and expenditure are not allocated to segments as this type of activity is driven by the central treasury activities, which manages the cash position of the Group.
|
| Six months ended 31.12.2015 |
| Six months ended31.12.2014 Restated |
| Year ended30.6.2015 | |||||
|
| Revenue | Segment Profit/ (loss) |
| Revenue | Segment Profit/ (loss) |
| Revenue | Segment Profit/ (loss) | ||
|
| £'000 | £'000 |
| £'000 | £'000 |
| £'000 | £'000 | ||
|
|
|
|
|
|
|
|
|
| ||
Professional services |
| 8,712 | 951 |
| 7,486 | 445 |
| 17,226 | 845 | ||
Healthcare |
| 5,596 | (53) |
| 5,894 | 238 |
| 13,688 | 984 | ||
Communications |
| 16,185 | 174 |
| 11,334 | 130 |
| 29,142 | 194 | ||
Central costs |
| - | (1,159) |
| - | (944) |
| - | (1,838) | ||
|
|
|
|
|
|
|
|
|
| ||
Total segmental result |
| 30,493 | (87) |
| 24,714 | (131) |
| 60,056 | 185 | ||
|
|
|
|
|
|
|
|
|
| ||
Highlighted items |
|
| - |
|
| 2,916 |
|
| 2,551 | ||
|
|
|
|
|
|
|
|
|
| ||
Operating (loss)/profit |
| (87) |
|
| 2,785 |
|
| 2,736 | |||
|
|
|
|
|
|
|
|
|
| ||
Interest |
|
| (1,267) |
|
| (1,038) |
|
| (2,231) | ||
|
|
|
|
|
|
|
|
|
| ||
(Loss)/profit before tax |
| (1,354) |
|
| 1,747 |
|
| 505 | |||
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
| ||
Adjusting for highlighted items note 5 |
|
|
|
|
|
|
|
| |||
Acquisition and merger costs | Recurring |
| - |
|
| 311 |
|
| 447 | ||
Bargain gain on acquisition | Non recurring |
| - |
|
| (3,227) |
|
| (3,227) | ||
Impairment charges | Non recurring |
| - |
|
| - |
|
| 229 | ||
|
|
| 0 |
|
| (2,916) |
|
| (2,551) | ||
|
|
|
|
|
|
|
|
|
| ||
| As at 31.12.15 | As at 31.12.14 | As at 30.6.15 | |||
|
|
| Restated | Restated | ||
| Segmental assets | Segmental liabilities | Segmental assets | Segmental liabilities | Segmental assets | Segmental liabilities |
| £'000 | £'000 | £'000 | £'000 | £'000 | £'000 |
Professional services | 21,511 | 22,335 | 20,746 | 19,059 | 22,392 | 21,481 |
Healthcare | 4,933 | 4,505 | 6,849 | 7,248 | 5,860 | 6,067 |
Communications | 19,396 | 16,508 | 19,668 | 15,444 | 20,461 | 17,106 |
|
|
|
|
|
|
|
Total | 45,840 | 43,348 | 47,263 | 41,751 | 48,713 | 44,654 |
|
|
|
|
|
|
|
Unallocated costs comprise central costs that are not considered attributable to the segments.
5. Highlighted items
The Group incurred costs during the period which we have highlighted. These costs include transaction costs, restructuring costs and other strategic, non-cash items including impairment, bargain gain on acquisition and non-recurring acquisition expenses. This has resulted in the following charges, gains and intangibles impairment as follows:
| Unaudited six months ended 31.12.2015 | Unaudited six months ended 31.12.2014 Restated | Audited year ended 30.6.2015 |
| £'000 | £'000 | £'000 |
Recurring |
|
|
|
Acquisition and merger costs | - | 311 | 447 |
Non- recurring |
|
|
|
Bargain gain on acquisition | - | (3,227) | (3,227) |
Impairment of intangibles | - | - | 229 |
Total highlighted costs | - | (2,916) | (2,551) |
6. Loss per share
This has been calculated on the loss for the period of £1,787,000 (2014 restated: Profit £1,747,000) and the number of shares used was 199,666,880 (2014: 199,666,880), being the weighted average number of share in issue during the period.
7. Dividends
No dividend is proposed for the six months ended 31 December 2015.
8. Copies of Interim financial statements
The Interim Results will be posted on the Company's web site www.progility.com
Related Shares:
Progility